To include your compound in the COVID-19 Resource Center, submit it here.

ABX grants Endocyte exclusive, worldwide rights to PSMA-targeting ligand

ABX GmbH (Radeberg, Germany) granted Endocyte Inc. (NASDAQ:ECYT) exclusive, worldwide rights to develop and commercialize prostate-specific membrane antigen (PSMA; FOLH1;

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE